Who
Patrick John Casey
Director
Company insider
Files Form 4 as: Director, Legend Biotech.
In numbers
- Trades disclosed
- 4
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $178K
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 30 Jun 2026
- Last trade
- 24 Sep 2026
- Last filed
- 28 Sep 2026
Companies traded
Activity over time
1 Jun – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Sep 2026filed 28 Sep 2026 | LEGN Legend BiotechBiotechnology | SEC FORM 4 Code A | —20,986 at $0.00 | filing |
| 24 Sep 2026filed 28 Sep 2026 | LEGN Legend BiotechBiotechnology | SEC FORM 4 Code A | —20,986 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | LEGN Legend BiotechBiotechnology | SEC FORM 4 Sold | $89K6,000 at $14.80 | filing |
| 30 Jun 2026filed 2 Jul 2026 | LEGN Legend BiotechBiotechnology | SEC FORM 4 Sold | $89K6,000 at $14.80 | filing |
News
Contrasting Legend Biotech (NASDAQ:LEGN) & Connect Biopharma (NASDAQ:CNTB)LEGN · tickerreport.com · 13 Oct 2026Financial Analysis: Q32 Bio (NASDAQ:QTTB) versus Legend Biotech (NASDAQ:LEGN)LEGN · themarketsdaily.com · 6 Oct 2026
0 headlines in the last 90 days name Patrick John Casey; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.